Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

IMMX vs SGMT: stock comparison and AI forecast

Immix Biopharma, Inc. (IMMX) and Sagimet Biosciences Inc. (SGMT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

IMMX Immix Biopharma, Inc.

Market Cap
$668M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

SGMT Sagimet Biosciences Inc.

Price
$9.85 +28.9% · 6M
Market Cap
$698M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

IMMX · SGMT

Key facts

  • IMMX and SGMT have similar market capitalizations ($668M and $698M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricIMMXSGMT
Market Cap$668M$698M
P/B Ratio2.92x–
EPS$-0.85$-1.52
Book Value/Share$2.76–
FCF/Share$-0.47–

Profitability & Margins

MetricIMMXSGMT
ROE-18.8%–
ROA-18.0%–
ROIC-18.2%–
Tax Rate-0.1%–

Financial Health

MetricIMMXSGMT
Current Ratio25.13x45.02x
D/E Ratio0.04x–
Financial Leverage1.04x–
Interest Coverage-3427.9x–
Working Capital$224M$239M

Cash Flow

MetricIMMXSGMT
Operating Cash Flow-$38M-$42M
Free Cash Flow-$39M–
Capital Spending-$590K–

Income Statement

MetricIMMXSGMT
Operating Income-$42M-$53M
Net Income-$43M–
R&D Expense$22M$35M

Dividend & Shareholder Information

MetricIMMXSGMT
Shares Outstanding83M71M
FAQ

IMMX vs SGMT: stock comparison and AI forecast

Which is bigger, IMMX or SGMT?

IMMX and SGMT have similar market capitalizations ($668M and $698M).

Which one does Intratio's AI model rank higher, IMMX or SGMT?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.